Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 27, 2023
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
[ Wed, Sep 27th 2023
] - WOPRAI
Tue, September 26, 2023
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
Ross Osborn Reiterated (AXGN) at Buy and Held Target at $16 on, Sep 26th, 2023
Ross Osborn of Cantor Fitzgerald, Reiterated "AxoGen, Inc." (AXGN) at Buy and Held Target at $16 on, Sep 26th, 2023.
Ross has made no other calls on AXGN in the last 4 months.
There is 1 other peer that has a rating on AXGN. Out of the 1 peers that are also analyzing AXGN, 0 agree with Ross's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ross
- Travis Steed of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $16 on, Tuesday, August 22nd, 2023
